Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001437749-25-024250
Filing Date
2025-07-31
Accepted
2025-07-31 20:38:50
Documents
2
Period of Report
2025-07-29

Document Format Files

Seq Description Document Type Size
1 FORM 4 rdgdoc.html 4  
1 FORM 4 rdgdoc.xml 4 2792
2 watson_poa.htm EX-24 8355
  Complete submission text file 0001437749-25-024250.txt   12887
Mailing Address 170 HARBOR WAY, SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 170 HARBOR WAY, SUITE 300 SOUTH SAN FRANCISCO CA 94080 (650) 550-3500
Vaxart, Inc. (Issuer) CIK: 0000072444 (see all company filings)

EIN.: 591212264 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 324 S. HYDE PARK AVENUE STE 350 TAMPA FL 33606
Business Address
Watson W. Mark (Reporting) CIK: 0001612372 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35285 | Film No.: 251173379